Patents by Inventor Benjamin D. Enerson

Benjamin D. Enerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEUTERATED FORMS OF TESTOSTERONE AND METHODS OF USE
    Publication number: 20240000799
    Abstract: Provided herein are compositions (e.g., pharmaceutical compositions) comprising deuterated testosterone, deuterated methyltestosterone, deuterated androstenedione, or derivatives thereof. The provided compositions and related methods may be useful for treating and/or preventing various diseases and conditions, such as hypogonadism, delay of growth and puberty, weight loss associated with HIV-associated wasting, vulvar dystrophies, micropenis, breast cancer, and sexual disorders.
    Type: Application
    Filed: December 2, 2021
    Publication date: January 4, 2024
    Applicant: Lennham Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Benjamin D. Enerson
  • DEUTERATED FORMS OF TESTOSTERONE AND METHODS OF USE
    Publication number: 20230124138
    Abstract: Provided herein are compositions (e.g., pharmaceutical compositions) comprising deuterated testosterone, deuterated methyltestosterone, or derivatives thereof. The provided compositions and related methods may be useful for treating and/or preventing various diseases and conditions, such as hypogonadism, delay of growth and puberty, weight loss associated with HIV-associated wasting, vulvar dystrophies, micropenis, breast cancer, and sexual disorders.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 20, 2023
    Applicant: Lennham Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Benjamin D. Enerson
  • Deuterated forms of testosterone and methods of use
    Patent number: 11471469
    Abstract: Provided herein are compositions (e.g., pharmaceutical compositions) comprising deuterated testosterone, deuterated methyltestosterone, or derivatives thereof. The provided compositions and related methods may be useful for treating and/or preventing various diseases and conditions, such as hypogonadism, delay of growth and puberty, weight loss associated with HIV-associated wasting, vulvar dystrophies, micropenis, breast cancer, and sexual disorders.
    Type: Grant
    Filed: December 20, 2021
    Date of Patent: October 18, 2022
    Assignee: Lennham Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Benjamin D. Enerson
  • DEUTERATED FORMS OF TESTOSTERONE AND METHODS OF USE
    Publication number: 20220175796
    Abstract: Provided herein are compositions (e.g., pharmaceutical compositions) comprising deuterated testosterone, deuterated methyltestosterone, or derivatives thereof. The provided compositions and related methods may be useful for treating and/or preventing various diseases and conditions, such as hypogonadism, delay of growth and puberty, weight loss associated with HIV-associated wasting, vulvar dystrophies, micropenis, breast cancer, and sexual disorders.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 9, 2022
    Applicant: Lennham Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Benjamin D. Enerson
  • Deuterated forms of testosterone and methods of use
    Patent number: 11202785
    Abstract: Provided herein are compositions (e,g., pharmaceutical compositions) comprising deuterated testosterone, deuterated methyltestosterone, or derivatives thereof. The provided compositions and related methods may be useful for treating and/or preventing various diseases and conditions, such as hypogonadism, delay of growth and puberty, weight loss associated with HIV-associated wasting, vulvar dystrophies, micropenis, breast cancer, and sexual disorders.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: December 21, 2021
    Assignee: Lennham Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Benjamin D. Enerson